We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Using ChatGPT Prompts to Enhance Clinical Data Analysis Through Coding

By Jen A. Miller (ADLM)
Posted on 29 Jun 2025
Clinical laboratorians are good at many things: communication, critical thinking, problem solving, and selecting the best possible testing solutions for patients and the healthcare professionals who treat them. More...


But what they may not be good at — and most people aren’t — is coding. Why would a clinical laboratorian need to know coding languages like Python or R?

“People are good with collecting the data but then not working with the data,” said Isaiah Mensah, PhD, clinical chemistry fellow in the department of pathology and immunology at Washington University School of Medicine in St. Louis.

In his roundtable session at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), Mensah will show attendees how to leverage generative artificial intelligence (AI) to jump over the coding hurdle, allowing them to access data-driven insights that were previously inaccessible to many in the field.

“We’re beginning to tackle questions that we couldn’t answer before,” said Mensah. Generative AI has made answering those questions easier for those who have a lot of data but don’t have a coding background — like clinical laboratorians.

Mensah will perform a live demonstration using real, anonymized patient data sets. He will prompt ChatGPT to obtain Python and R code and then apply that code to analyze complex clinical data. He will also lead a group discussion to guide attendees who want to conduct similar analyses. In fact, he encourages participants to bring their computers to work with the group on their own data (without any personally identifiable information).

“My goal is to share data sets with them and hopefully we can go through using ChatGPT prompts to ask specific questions,” Mensah said. “I’ll have different ways of asking for codes using different prompts, then give [attendees] some guidelines on how to maximize prompts.” He will also discuss how to format data optimally. Otherwise, it’s “garbage in, garbage out.”

Learning to perform complex analyses is critical for laboratorians because clinical labs collect a high volume of data. “At my institution, we have over one million specimens per year,” Mensah said. “We take data on age, sex, analytes, and results. We produce the most data, so it only makes sense that we will be able to ask questions about the data that we collect, and we’ll be able to answer them.”
 
The session will also be of interest to healthcare professionals who don’t regularly handle large data sets, including physicians, Mensah said. “We all have access to data one way or the other,” he said. “It’s so helpful for people to know how to use the power of AI to improve their data analysis.”

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.